These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 374869)

  • 1. Five cultivable mycobacterial strains giving blast transformation and leukocyte migration inhibition of leukocytes analogous to mycobacterium leprae.
    Mustafa AS; Talwar GP
    Lepr India; 1978 Oct; 50(4):498-508. PubMed ID: 374869
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy.
    Myrvang B; Godal T; Ridley DS; Fröland SS; Song YK
    Clin Exp Immunol; 1973 Aug; 14(4):541-53. PubMed ID: 4583777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed hypersensitivity skin reactions to homologous and heterologous antigens in guinea-pigs immunized with M. leprae and four selected cultivable mycobacterial strains.
    Mustafa AS; Talwar GP
    Lepr India; 1978 Oct; 50(4):509-19. PubMed ID: 374870
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro stimulation of human lymphocytes with mycobacterial antigens.
    Wright EP; Rangarajan R
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):455-7. PubMed ID: 7042608
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of T-cell-activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG, and mycobacterium w.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):265-73. PubMed ID: 3045224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of skin tests with five different mycobacteria.
    Girdhar BK; Desikan KV
    Lepr India; 1978 Oct; 50(4):555-9. PubMed ID: 374873
    [No Abstract]   [Full Text] [Related]  

  • 8. Limiting dilution of murine T cell response to mycobacterial antigens.
    Launois P; Maillere B; Dieye A; Sarthou JL; Bach MA
    Acta Leprol; 1989; 7 Suppl 1():179-80. PubMed ID: 2503983
    [No Abstract]   [Full Text] [Related]  

  • 9. Cross-reactions between mycobacteria. II. Crossed immunoelectrophoretic analysis of soluble antigens of BCG and comparison with other mycobacteria.
    Harboe M; Mshana RN; Closs O; Kronvall G; Axelsen NH
    Scand J Immunol; 1979; 9(2):115-24. PubMed ID: 106465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigeneic cross-reactivity between ICRC-bacilli and M. leprae--"in vitro" evaluation.
    Kale VP; Bapat CV
    Indian J Lepr; 1984; 56(2):219-31. PubMed ID: 6387004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of immunizing and delayed hypersensitivity eliciting antigens of Mycobacterium leprae, M. tuberculosis, M. vaccae, and M. bovis (BCG).
    Sinha S; Sreevatsa ; Gupta SK; Sengupta U
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):42-53. PubMed ID: 2435824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids.
    Fournie JJ; Adams E; Mullins RJ; Basten A
    Infect Immun; 1989 Nov; 57(11):3653-9. PubMed ID: 2572559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and late reactions in tuberculoid and lepromatous leprosy patients with lepromins from Mycobacterium leprae and five selected cultivable mycobacteria.
    Mustafa AS; Talwar GP
    Lepr India; 1978 Oct; 50(4):566-71. PubMed ID: 374875
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune responses to mycobacterium leprae in man.
    Myrvang B
    J Oslo City Hosp; 1975 Jan; 25(1):3-24. PubMed ID: 1092818
    [No Abstract]   [Full Text] [Related]  

  • 15. Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients.
    Brett SJ; Kingston AE; Colston MJ
    Clin Exp Immunol; 1987 Jun; 68(3):510-20. PubMed ID: 3308217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The characterization and immunoreactivity of a 70 kD protein common to Mycobacterium leprae and Mycobacterium bovis (BCG).
    Britton WJ; Garsia RJ; Hellqvist L; Watson JD; Basten A
    Lepr Rev; 1986 Dec; 57 Suppl 2():67-75. PubMed ID: 3553805
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of "reactions" in borderline tuberculoid (BT) leprosy. A preliminary report.
    Godal T; Myrvang B; Samuel DR; Ross WF; Lofgren M
    Acta Pathol Microbiol Scand Suppl; 1973; 236(0):45-53. PubMed ID: 4602874
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed hypersensitivity skin reactions to lepromin and antigens prepared from four other mycobacteria.
    Govil DC; Bhutani LK
    Lepr India; 1978 Oct; 50(4):550-4. PubMed ID: 374872
    [No Abstract]   [Full Text] [Related]  

  • 19. [Change in cell-mediated immunity to Mycobacterium leprae and Mycobacterium marinum in Hansen's disease patients].
    Fliess EL; Ortiz MC; Corn J
    Hansenol Int; 1983 Jun; 8(1):9-17. PubMed ID: 6432692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of circulating immune complexes of leprosy patients on leukocyte migration inhibition induced by Mycobacterium leprae antigens in healthy volunteers.
    Tyagi P; Girdhar BK; Katoch K; Sengupta V
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):487-92. PubMed ID: 1890375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.